Torre F - Search Results

1

A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects?

Icardi G, Bruzzone B, Gota F, Torre F, Giannini E, Massone L, Li Bassi A, Lai PL, Picciotto A, Ansaldi F. Icardi G, et al. Among authors: torre f. Ann Ig. 2003 Nov-Dec;15(6):863-70. Ann Ig. 2003. PMID: 15049543

2

Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping.

Ansaldi F, Torre F, Bruzzone BM, Picciotto A, Crovari P, Icardi G. Ansaldi F, et al. Among authors: torre f. J Med Virol. 2001 Jan;63(1):17-21. J Med Virol. 2001. PMID: 11130882

3

Antiviral activity of amantadine in elderly patients with chronic hepatitis C.

Torre F, Campo N, Giusto R, Ansaldi F, Icardi GC, Picciotto A. Torre F, et al. Gerontology. 2001 Nov-Dec;47(6):330-3. doi: 10.1159/000052823. Gerontology. 2001. PMID: 11721147 Clinical Trial.

4

Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients.

Campo N, Sinelli N, Brizzolara R, Torre F, Gurreri G, Russo R, Saffioti S, Celle G, Picciotto A. Campo N, et al. Among authors: torre f. Nephron. 1999;82(1):17-21. doi: 10.1159/000045362. Nephron. 1999. PMID: 10224479

5

Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C.

Pelli N, Torre F, Delfino A, Basso M, Picciotto A. Pelli N, et al. Among authors: torre f. J Interferon Cytokine Res. 2006 Feb;26(2):119-23. doi: 10.1089/jir.2006.26.119. J Interferon Cytokine Res. 2006. PMID: 16487032

6

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.

Basso M, Giannini EG, Torre F, Blanchi S, Savarino V, Picciotto A. Basso M, et al. Among authors: torre f. Hepatology. 2009 May;49(5):1442-8. doi: 10.1002/hep.22810. Hepatology. 2009. PMID: 19350657

7

Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients.

Torre F, Giannini EG, Basso M, Fazio V, Savarino V, Picciotto A. Torre F, et al. J Gastrointestin Liver Dis. 2011 Mar;20(1):47-50. J Gastrointestin Liver Dis. 2011. PMID: 21451797 Free article.

8

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Torre F, Rossol S, Pelli N, Basso M, Delfino A, Picciotto A. Torre F, et al. Clin Exp Immunol. 2004 Jun;136(3):507-12. doi: 10.1111/j.1365-2249.2004.02476.x. Clin Exp Immunol. 2004. PMID: 15147353 Free PMC article.

9

Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.

Torre F, Mattioli F, Campo N, Delfino A, Basso M, Pelli N, Martelli A, Picciotto A. Torre F, et al. Dig Liver Dis. 2004 Oct;36(10):677-81. doi: 10.1016/j.dld.2004.03.020. Dig Liver Dis. 2004. PMID: 15506667

10

Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.

Pelli N, Floreani A, Torre F, Delfino A, Baragiotta A, Contini P, Basso M, Picciotto A. Pelli N, et al. Among authors: torre f. Clin Exp Immunol. 2007 Apr;148(1):85-9. doi: 10.1111/j.1365-2249.2006.03293.x. Clin Exp Immunol. 2007. PMID: 17302732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

683 results

Search Page